EUVIMEDObjevte EUVIMED
Crossref

A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer

Jing Jin, Yao Jin, Rong Zhang, Ying Li, Zhi-Ying Zhou, Jin-Peng Feng, Yan-Tong Liu, Zhi-Jie Sun, Zhi-Yin Xiao iD, De-Li Dong iD

British Journal of Pharmacology · 2026-11 · 183 (21) · 6404-6421

DOI: 10.1111/bph.70614 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-07-30. Written by Jing Jin and 9 co-authors. Institution: Department of Pharmacology, China Pharmaceutical University, Nanjing, 211198, China. Major MEDLINE topics: Urinary Bladder Neoplasms, Quinolines, Antineoplastic Agents, Carbon Monoxide. Cited 1 times so far (Crossref); 62 references. Funded by: Jiaxing Medical Key Subject Funding of Zhejiang Province, the Jiaxing Key Laboratory of Precise Diagnosis and Treatment of Urological Tumor, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Bladder cancer remains a significant burden on public health globally. Carbon monoxide (CO) has emerged as a promising therapeutic agent for cancers because of its key role in inducing mitochondrial dysfunction and metabolic reprogramming in cancer cells; however, its clinical translation has been hindered by systemic toxicity because of its binding to haemoglobin, which is avoided by localised intravesical therapy via the bladder. This study aimed to develop and characterise a novel manganese(I)‐based CO releasing molecular MnCORM as a therapeutic agent against bladder cancer. Experimental Approach A new MnCORM chelate of a quinoline derivative was synthesised and characterised, and its anti‐cancer efficacy was assessed using a 2D bladder cancer cell model, a 3D tumour spheroid model, and a murine orthotopic bladder cancer model. Molecular mechanisms were explored via staining assays, transmission electron microscopy (TEM) and western blots. Key Results MnCORM inhibited cell viability and induced cell death in T24 and RT112 bladder cancer cells. MnCORM activated AMPK, whereas the AMPK inhibitor Compound C mitigated MnCORM‐induced cytotoxicity in T24 cancer cells. MnCORM induced AMPK‐triggered and Drp1‐dependent mitochondrial fission, promoted reactive oxygen species (ROS) accumulation, and induced mitophagy‐associated cell death. The inhibitory effect of MnCORM on tumour growth was validated in a 3D tumour spheroid model and further proven in an orthotopic bladder cancer model in nude mice after intravesical instillation of MnCORM (1 mg kg −1 ). Conclusions and Implications Our work shows that MnCORM could be potentially applied for bladder cancer therapy through intravesical instillation with less systemic toxicity.

Subjects

MeSH terms (MEDLINE)

Urinary Bladder NeoplasmsQuinolinesAntineoplastic AgentsCarbon MonoxideManganeseAnimalsHumansCell Line, TumorMiceFemaleCell SurvivalAdministration, IntravesicalMice, Nude

Author keywords

bladder cancercarbon monoxidemanganese carbonyl compoundsquinoline

Substances

QuinolinesAntineoplastic AgentsCarbon MonoxideManganesequinoline

Authors and institutions

  • Department of Pharmacology, China Pharmaceutical University, Nanjing, 211198, China.
  • Department of Urology, The Affiliated Hospital of Jiaxing University, Jiaxing, 314001, China.
  • College of Biological, Chemical Sciences and Engineering, Jiaxing University, Jiaxing, 314001, China.
  • College of Medical, Jiaxing University, Jiaxing, 314001, China.

ORCID profiles: Zhi-Yin Xiao, De-Li Dong

Funding

  • Jiaxing Medical Key Subject Funding of Zhejiang Province
  • the Jiaxing Key Laboratory of Precise Diagnosis and Treatment of Urological Tumor
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Jiaxing University

Cite

APA

Jin, J., Jin, Y., Zhang, R., Li, Y., Zhou, Z. Y., Feng, J. P., Liu, Y. T., Sun, Z. J., Xiao, Z. Y., & Dong, D. L. (2026). A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer. British Journal of Pharmacology, 183(21), 6404-6421. https://doi.org/10.1111/bph.70614

Vancouver

Jin J, Jin Y, Zhang R, Li Y, Zhou ZY, Feng JP, et al. A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer. British Journal of Pharmacology. 2026;183(21):6404-6421. doi:10.1111/bph.70614

BibTeX
@article{Jin2026,
  author = {Jin, Jing and Jin, Yao and Zhang, Rong and Li, Ying and Zhou, Zhi-Ying and Feng, Jin-Peng and Liu, Yan-Tong and Sun, Zhi-Jie and Xiao, Zhi-Yin and Dong, De-Li},
  title = {A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {21},
  pages = {6404--6421},
  doi = {10.1111/bph.70614}
}
Start for free →